Literature DB >> 8446953

A quantitative, semi-automated and computer-assisted test for lupus anticoagulant.

R Schjetlein1, K E Sletnes, F Wisløff.   

Abstract

We describe the design of a quantitative test for lupus anticoagulants (LA), based on the Activated Partial Thromboplastin Time (APTT) and the Russell Viper Venom Time (RVVT). In this assay system, test plasmas mixed 1:1 with a pooled normal plasma (NP) are tested at a low as well as a high cephalin concentration, using an ACL 3000 automated clot timer. The ratio of these two clotting times, divided by the corresponding ratio for the NP, was defined as the Lupus Ratio (LR) and calculated by means of a computer program. The frequency distribution of the LR in a reference population of 150 healthy individuals was determined, and the 97.5 percentile was defined as the upper reference limit and allocated the value one Lupus Anticoagulant Unit (LA-U). Using dilutions of one strong LA positive plasma, standard curves for LA-U determination were constructed for the APTT as well as the RVVT based test, and fitted with a log-logit computer model. The sensitivity of the tests was comparable to that of the Kaolin Clotting Time (KCT). Plasma samples from warfarin treated patients were uniformly negative, while most heparin-containing plasmas were positive in both tests. Plasmas deficient in Factors V, VIII and IX were negative, whereas one Factor VIII-inhibitor containing plasma was positive in the APTT and negative in the RVVT. The present work shows that it is possible to adapt the APPT as well as the RVVT for LA quantification. With an automated clot timer and computer based calculation of results, the assays are simple and reproducible and have a high sensitivity and specificity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446953     DOI: 10.1016/0049-3848(93)90049-t

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

1.  Detection of cerebral embolic signals in patients with systemic lupus erythematosus.

Authors:  A Dahl; R Omdal; K Waterloo; O Joakimsen; E A Jacobsen; W Koldingsnes; S I Mellgren
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02-24       Impact factor: 10.154

2.  Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene.

Authors:  Eva M Jacobsen; Elin J Trettenes; Finn Wisløff; Ulrich Abildgaard
Journal:  Thromb J       Date:  2006-01-25

3.  Complex formation of anti-VEGF-C with VEGF-C released during blood coagulation resulted in an artifact in its serum pharmacokinetics.

Authors:  Daniela Bumbaca Yadav; Arthur E Reyes; Priyanka Gupta; Jean-Michel Vernes; Y Gloria Meng; Michelle G Schweiger; Shannon L Stainton; Germaine Fuh; Paul J Fielder; Amrita V Kamath; Ben-Quan Shen
Journal:  Pharmacol Res Perspect       Date:  2020-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.